
Associate Professor Ziad Hijazi
Uppsala University, Uppsala (Sweden)
Membership:
FESC Member
EHRA Member
Follow
Biography
Dr. Ziad Hijazi is an Associate Professor of Cardiology at Uppsala University. He holds a Ph.D. in medical sciences and has extensive experience in clinical research, with emphasis on atrial fibrillation, biomarkers, clinical risk stratification, stroke prevention, and precision medicine, including registry-embedded randomized trials. He currently serves as Senior Medical Director at Thermo Fisher Scientific, providing medical oversight across cardiovascular clinical trials and scientific and strategic expertise to CVRM drug development programs. Dr. Hijazi has also been a national coordinator, steering committee member, and coordinating investigator in several large-scale cardiovascular studies, including clinical events committees, and is an editorial board member of Circulation.
Contributor content
Session
Pulsed field ablation in persistent atrial fibrillation
12 April 2026
Session
Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
2 September 2019
Session
Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
31 August 2019


